REG-BARCLAYS PLC Form 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
Form 8.3 - STERIS CORPORATION
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the Code)
1. KEY INFORMATION
| (a) | Full name of discloser: | Barclays PLC. | |||
| (b) | Owner or controller of interest and short | ||||
| positions disclosed, if different from 1(a): | |||||
| (c) | Name of offeror/offeree in relation to whose | STERIS CORPORATION | |||
| relevant securities this form relates: | |||||
| (d) | If an exempt fund manager connected with an | ||||
| offeror/offeree, state this and specify identity of | |||||
| offeror/offeree: | |||||
| (e) | Date position held/dealing undertaken: | 02 October 2015 | |||
| (f) | In addition to the company in 1(c) above, is the discloser making | YES: | |||
| disclosures in respect of any other party to the offer? | SYNERGY HEALTH PLC |
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
| Class of relevant security: | ORD | ||||||||||
| Interests | Short Positions | ||||||||||
| Number | (%) | Number | (%) | ||||||||
| (1) | Relevant securities owned | ||||||||||
| and/or controlled: | 2,821 | 0.00% | 244,843 | 0.41% | |||||||
| (2) | Cash-settled derivatives: | ||||||||||
| 284,112 | 0.47% | 0 | 0.00% | ||||||||
| (3) | Stock-settled derivatives (including options) | ||||||||||
| and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | |||||||
| (4) | |||||||||||
| TOTAL: | 286,933 | 0.48% | 244,843 | 0.41% | |||||||
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form8 (Open Positions).
(b) Rights to subscribe for new securities (including directors and other employee options)
| Class of relevant security in relation to which subscription right exists: | |
| Details, including nature of the rights concerned and relevant percentages: |
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
| Class of relevant | Purchase/sale | Number of | Price per unit | ||||
| security | securities | ||||||
| ORD | Purchase | 150 | 65.2933 USD | ||||
| ORD | Purchase | 165 | 65.1603 USD | ||||
| ORD | Purchase | 200 | 65.2762 USD | ||||
| ORD | Purchase | 300 | 65.0933 USD | ||||
| ORD | Purchase | 300 | 64.6896 USD | ||||
| ORD | Purchase | 350 | 65.2835 USD | ||||
| ORD | Purchase | 400 | 65.1850 USD | ||||
| ORD | Purchase | 432 | 65.0349 USD | ||||
| ORD | Purchase | 493 | 65.3000 USD | ||||
| ORD | Purchase | 514 | 64.5935 USD | ||||
| ORD | Purchase | 610 | 64.8063 USD | ||||
| ORD | Purchase | 695 | 65.0136 USD | ||||
| ORD | Purchase | 905 | 64.7916 USD | ||||
| ORD | Purchase | 1,038 | 64.1878 USD | ||||
| ORD | Purchase | 1,300 | 64.2413 USD | ||||
| ORD | Purchase | 3,500 | 64.1568 USD | ||||
| ORD | Purchase | 5,600 | 64.0955 USD | ||||
| ORD | Purchase | 6,296 | 64.0267 USD | ||||
| ORD | Purchase | 10,421 | 64.0686 USD | ||||
| ORD | Sale | 100 | 65.2725 USD | ||||
| ORD | Sale | 100 | 63.8320 USD | ||||
| ORD | Sale | 100 | 64.2200 USD | ||||
| ORD | Sale | 100 | 64.1400 USD | ||||
| ORD | Sale | 100 | 63.8850 USD | ||||
| ORD | Sale | 100 | 63.9000 USD | ||||
| ORD | Sale | 200 | 63.6900 USD | ||||
| ORD | Sale | 250 | 65.2880 USD | ||||
| ORD | Sale | 300 | 63.9466 USD | ||||
| ORD | Sale | 300 | 63.8833 USD | ||||
| ORD | Sale | 350 | 65.2836 USD | ||||
| ORD | Sale | 398 | 64.1501 USD | ||||
| ORD | Sale | 400 | 64.5187 USD | ||||
| ORD | Sale | 400 | 64.1812 USD | ||||
| ORD | Sale | 493 | 65.3000 USD | ||||
| ORD | Sale | 600 | 63.8150 USD | ||||
| ORD | Sale | 800 | 64.1031 USD | ||||
| ORD | Sale | 1,000 | 63.9490 USD | ||||
| ORD | Sale | 1,140 | 63.8954 USD | ||||
| ORD | Sale | 1,400 | 64.1062 USD | ||||
| ORD | Sale | 1,518 | 64.9876 USD | ||||
| ORD | Sale | 1,695 | 65.0108 USD | ||||
| ORD | Sale | 1,800 | 63.8622 USD | ||||
| ORD | Sale | 2,112 | 64.8744 USD | ||||
| ORD | Sale | 2,214 | 64.0412 USD | ||||
| ORD | Sale | 2,896 | 64.1014 USD | ||||
| ORD | Sale | 4,200 | 64.0920 USD | ||||
| ORD | Sale | 4,203 | 63.9509 USD | ||||
| ORD | Sale | 5,400 | 64.1199 USD |
(b) Cash-settled derivative transactions
| Class of relevant security | Product description e.g. CFD | Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position | Number of reference securities | Price per unit |
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
| Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates | Exercise price per unit | Type e.g. American, European etc. | Expiry date | Option money paid/ received per unit |
(ii) Exercise
| Class of relevant security | Product description e.g. call option | Exercising/ exercised against | Number of securities | Exercise price per unit |
(d) Other dealings (including subscribing for new securities)
| Class of relevant security | Nature of dealing e.g. subscription, conversion | Details | Price per unit (if applicable) |
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
| Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none |
(b) Agreements, arrangements or understandings relating to options or derivatives
| Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none |
(c) Attachments
| Is a Supplemental Form 8 (Open Positions) attached? | NO | ||
| Date of disclosure: | 5 Oct 2015 | ||
| Contact name: | Jay Supaya | ||
| Telephone number: | 020 7773 0635 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151005005992/en/
BARCLAYS PLC
Recent news on Steris
See all newsREG - Travelex Financing - Update on debt restructuring
AnnouncementREG - Synergy Health Steris Corp. - Scheme Effective <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - State Street Global Steris Corp. Synergy Health - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - Legal&Gen Inv Mgmnt Synergy Health Steris Corp. - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG-BARCLAYS PLC FORM 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
Announcement